These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 10807036)

  • 1. Structure-activity relationship at the leucine side chain in a series of N,N-dialkyldipeptidyl-amines as N-type calcium channel blockers.
    Ryder TR; Hu LY; Rafferty MF; Lotarski SM; Rock DM; Stoehr SJ; Taylor CP; Weber ML; Miljanich GP; Millerman E; Szoke BG
    Drug Des Discov; 2000; 16(4):317-22. PubMed ID: 10807036
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure-activity study of L-cysteine-based N-type calcium channel blockers: optimization of N- and C-terminal substituents.
    Seko T; Kato M; Kohno H; Ono S; Hashimura K; Takimizu H; Nakai K; Maegawa H; Katsube N; Toda M
    Bioorg Med Chem Lett; 2002 Mar; 12(6):915-8. PubMed ID: 11958993
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design and biological evaluation of non-peptide analogues of omega-conotoxin MVIIA.
    Menzler S; Bikker JA; Suman-Chauhan N; Horwell DC
    Bioorg Med Chem Lett; 2000 Feb; 10(4):345-7. PubMed ID: 10714496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and SAR studies of a novel series of T-type calcium channel blockers.
    Park SJ; Park SJ; Lee MJ; Rhim H; Kim Y; Lee JH; Chung BY; Lee JY
    Bioorg Med Chem; 2006 May; 14(10):3502-11. PubMed ID: 16434203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure-activity relationships of omega-conotoxins at N-type voltage-sensitive calcium channels.
    Nielsen KJ; Schroeder T; Lewis R
    J Mol Recognit; 2000; 13(2):55-70. PubMed ID: 10822250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design, Synthesis and Biological Evaluation of Two Opioid Agonist and Cav 2.2 Blocker Multitarget Ligands.
    Mollica A; Costante R; Novellino E; Stefanucci A; Pieretti S; Zador F; Samavati R; Borsodi A; Benyhe S; Vetter I; Lewis RJ
    Chem Biol Drug Des; 2015 Aug; 86(2):156-62. PubMed ID: 25393330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analgesic (omega)-conotoxins CVIE and CVIF selectively and voltage-dependently block recombinant and native N-type calcium channels.
    Berecki G; Motin L; Haythornthwaite A; Vink S; Bansal P; Drinkwater R; Wang CI; Moretta M; Lewis RJ; Alewood PF; Christie MJ; Adams DJ
    Mol Pharmacol; 2010 Feb; 77(2):139-48. PubMed ID: 19892914
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-activity study and analgesic efficacy of amino acid derivatives as N-type calcium channel blockers.
    Seko T; Kato M; Kohno H; Ono S; Hashimura K; Takimizu H; Nakai K; Maegawa H; Katsube N; Toda M
    Bioorg Med Chem Lett; 2001 Aug; 11(16):2067-70. PubMed ID: 11514140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure-activity study of L-amino acid-based N-type calcium channel blockers.
    Seko T; Kato M; Kohno H; Ono S; Hashimura K; Takimizu H; Nakai K; Maegawa H; Katsube N; Toda M
    Bioorg Med Chem; 2003 Apr; 11(8):1901-13. PubMed ID: 12659776
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The structure-activity relationship study on 2-, 5-, and 6-position of the water soluble 1,4-dihydropyridine derivatives blocking N-type calcium channels.
    Yamamoto T; Niwa S; Ohno S; Tokumasu M; Masuzawa Y; Nakanishi C; Nakajo A; Onishi T; Koganei H; Fujita S; Takeda T; Kito M; Ono Y; Saitou Y; Takahara A; Iwata S; Shoji M
    Bioorg Med Chem Lett; 2008 Sep; 18(17):4813-6. PubMed ID: 18684623
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple parallel synthesis of N,N-dialkyldipeptidylamines as N-type calcium channel blockers.
    Ryder TR; Hu LY; Rafferty MF; Millerman E; Szoke BG; Tarczy-Hornoch K
    Bioorg Med Chem Lett; 1999 Jul; 9(13):1813-8. PubMed ID: 10406647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Binding of Ala-scanning analogs of omega-conotoxin MVIIC to N- and P/Q-type calcium channels.
    Sato K; Raymond C; Martin-Moutot N; Sasaki T; Ohtake A; Minami K; Van Renterghem C; Kim JI; Takahashi M; Seagar MJ
    FEBS Lett; 2000 Mar; 469(2-3):147-50. PubMed ID: 10713260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure-activity relationships of diphenylpiperazine N-type calcium channel inhibitors.
    Pajouhesh H; Feng ZP; Ding Y; Zhang L; Pajouhesh H; Morrison JL; Belardetti F; Tringham E; Simonson E; Vanderah TW; Porreca F; Zamponi GW; Mitscher LA; Snutch TP
    Bioorg Med Chem Lett; 2010 Feb; 20(4):1378-83. PubMed ID: 20117000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bioactive Mimetics of Conotoxins and other Venom Peptides.
    Duggan PJ; Tuck KL
    Toxins (Basel); 2015 Oct; 7(10):4175-98. PubMed ID: 26501323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure-activity relationship of N-methyl-N-aralkyl-peptidylamines as novel N-type calcium channel blockers.
    Hu LY; Ryder TR; Rafferty MF; Dooley DJ; Geer JJ; Lotarski SM; Miljanich GP; Millerman E; Rock DM; Stoehr SJ; Szoke BG; Taylor CP; Vartanian MG
    Bioorg Med Chem Lett; 1999 Aug; 9(15):2151-6. PubMed ID: 10465535
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery and SAR of novel tetrahydropyrrolo[3,4-c]pyrazoles as inhibitors of the N-type calcium channel.
    Winters MP; Subasinghe N; Wall M; Beck E; Brandt MR; Finley MF; Liu Y; Lubin ML; Neeper MP; Qin N; Flores CM; Sui Z
    Bioorg Med Chem Lett; 2014 May; 24(9):2053-6. PubMed ID: 24726802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Closed-state inactivation and pore-blocker modulation mechanisms of human Ca
    Dong Y; Gao Y; Xu S; Wang Y; Yu Z; Li Y; Li B; Yuan T; Yang B; Zhang XC; Jiang D; Huang Z; Zhao Y
    Cell Rep; 2021 Nov; 37(5):109931. PubMed ID: 34731621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery of diphenyl lactam derivatives as N-type calcium channel blockers.
    Doherty GA; Bhatia P; Vortherms TA; Marsh KC; Wetter JM; Mack H; Scott VE; Jarvis MF; Stewart AO
    Bioorg Med Chem Lett; 2012 Feb; 22(4):1716-8. PubMed ID: 22277280
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel series of pyrazolylpiperidine N-type calcium channel blockers.
    Subasinghe NL; Wall MJ; Winters MP; Qin N; Lubin ML; Finley MF; Brandt MR; Neeper MP; Schneider CR; Colburn RW; Flores CM; Sui Z
    Bioorg Med Chem Lett; 2012 Jun; 22(12):4080-3. PubMed ID: 22608964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. N,N-dialkyl-dipeptidylamines as novel N-type calcium channel blockers.
    Hu LY; Ryder TR; Rafferty MF; Cody WL; Lotarski SM; Miljanich GP; Millerman E; Rock DM; Song Y; Stoehr SJ; Taylor CP; Weber ML; Szoke BG; Vartanian MG
    Bioorg Med Chem Lett; 1999 Mar; 9(6):907-12. PubMed ID: 10206559
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.